Provider
P66-17 Clarification of Mid-Level Definitions
Program effective Date: Nov 06, 2017
Search Results
Displaying 3251 - 3260 of 3690 results
Provider
P17-17 Addition of Drug Kisqali to the Self-Administered Oncology Prior Authorization with Quantity Limit Program
Program effective Date: Apr 28, 2017
Provider
P22-17 Identified Claims Processing Issues Grid
Program effective Date: May 10, 2017
Provider
P35-16 Requirement to Submit National Drug Codes and Related Information
Program effective Date: Jul 27, 2016
Provider
P27-16 Changes to Prior Authorization Requirements for Select Services for Commercial Products
Program effective Date: Jun 08, 2016
Provider
P4-17 Addition of Drug to the Self-Administered Oncology Prior Authorization with Quantity Limit Program
Program effective Date: Jan 30, 2017
Provider
P34-16 New Drug-Related Prior Authorization Criteria for Hyperpolarization-Activated Cyclic Nucleotide-Gated (HCN) Channel Blocker Prior Authorization with Quantity Limit Program
Program effective Date: Jul 27, 2016
Provider
P47-16 New Drug-Related Prior Authorization Requirements for Botulinum Toxin, Remicade, Rituxan and Biologic Immunomodulators
Program effective Date: Oct 10, 2016
Provider
P50-16 Addition of a Drug (Xiidra) to the Ophthalmic Immunomodulators Prior Authorization with Quantity Limit Program
Program effective Date: Oct 28, 2016
Provider
P53-16 New Notification Requirement for Outpatient Dialysis Services for Commercial Products and Subscribers in Government Programs
Program effective Date: Nov 09, 2016